Trial of Cardiac Magnetic Resonance Imaging (MRI) Versus Cardiac Catheterization Prior to Glenn Operation
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This study is a prospective, randomized study of patients with single ventricle heart disease who are to undergo superior cavo-pulmonary anastomosis, or "Glenn" operation. Such patients have historically undergone cardiac catheterization to ensure suitability for the procedure. Cardiac magnetic resonance imaging (cardiac MRI) is a newer technology that provides excellent anatomic and functional imaging of the heart. This study is designed to demonstrate our hypothesis that cardiac magnetic resonance imaging will provide comparable information to catheterization, with less side effects.
| Condition | Intervention |
|---|---|
|
Congenital Heart Defects |
Procedure: Diagnostic cardiac MRI Procedure: Cardiac catheterization |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Diagnostic |
| Official Title: | Clinical Trial of Cardiac Magnetic Resonance Imaging in Routine Evaluation Prior to Superior Cavo-Pulmonary Anastomosis |
- Toxicity profile for each group [ Time Frame: 3 Months Post-Glenn operation ] [ Designated as safety issue: Yes ]
- Operative and post-operative outcomes [ Time Frame: 30 days post-operation ] [ Designated as safety issue: Yes ]
- Missed diagnoses [ Time Frame: 3 months post-Glenn operation ] [ Designated as safety issue: Yes ]
- Cost [ Time Frame: Pre-operative evaluation ] [ Designated as safety issue: No ]
- Clinical Definition of successful Glenn operation [ Time Frame: 3 months post-operatively ] [ Designated as safety issue: Yes ]
| Enrollment: | 80 |
| Study Start Date: | January 2004 |
| Study Completion Date: | January 2008 |
| Primary Completion Date: | June 2006 (Final data collection date for primary outcome measure) |
-
Procedure: Diagnostic cardiac MRI
This is a prospective, randomized study of patients with single ventricle congenital heart disease presenting for superior cavo-pulmonary anastomosis, or "Glenn" operation. Such patients in the past have routinely undergone pre-operative invasive cardiac catheterization to assess anatomic and hemodynamic suitability for this procedure. Recent retrospective reviews, including our own (J Thorac Cardiovasc Surg 2003: July;126(1):272-81) have suggested that such catheterization may not benefit many patients, and that non-invasive assessment may allow adequate evaluation while avoiding many (typically minor) complications seen with cardiac catheterization in this high risk group of infants. Cardiac MRI is a non-invasive imaging modality that can deliver superior anatomic information (such as vascular and intracardiac anatomy) as well as functional data (ventricular volumes and ejection fraction), and may be a safe alternative to catheterization in such patients. In this study, patients undergo screening echocardiogram prior to enrollment in the study to assess degree of risk for the operation (such as pulmonary vein obstruction, a clear risk factor for poor outcome) or for demonstrated need for catheterization intervention (such as aortic arch obstruction requiring balloon dilation); patients with low risk echocardiograms whose parents grant informed consent for the study are then randomized in a prospective fashion to cardiac MRI or cardiac catheterization. The findings of each study are then reviewed by the subject's cardiologist and cardiac surgeon; patients in whom further pre-operative information may cross over to another study if deemed necessary (such as catheterization in patients in whom an unsuspected finding is noted, or cardiac MRI in patients in whom further functional data may be desired). Patients are followed for details of the hospital stay (including hospital length of stay, complications, hospital charges) for the pre-operative testing, as well as operative and post-operative outcomes (new/missed diagnoses, hospital stay, operative and post-operative complications, achievement of a clinical definition of a "good" outcome from the Glenn operation).
Eligibility| Ages Eligible for Study: | 6 Weeks to 5 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Single ventricle heart disease patients presenting for Glenn operation
Exclusion Criteria:
- Aortic arch obstruction
- Pulmonary vein stenoses
- Severe ventricular dysfunction
- Pulmonary hypertension
Contacts and Locations| United States, Massachusetts | |
| Childrens Hospital, Boston | |
| Boston, Massachusetts, United States, 02115 | |
| Principal Investigator: | David W. Brown, MD | Childrens Hospital Boston |
More Information
Publications:
| Responsible Party: | David W. Brown, MD. Principal Investigator, Childrens Hospital Boston |
| ClinicalTrials.gov Identifier: | NCT00112424 History of Changes |
| Other Study ID Numbers: | CH 02-12-155 |
| Study First Received: | June 2, 2005 |
| Last Updated: | January 29, 2008 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Children's Hospital Boston:
|
Superior cavo-pulmonary anastomosis Glenn operation Congenital heart defects Cardiac magnetic resonance imaging |
Additional relevant MeSH terms:
|
Heart Defects, Congenital Cardiovascular Abnormalities Cardiovascular Diseases Heart Diseases Congenital Abnormalities |
ClinicalTrials.gov processed this record on May 21, 2013